Case: A Case of Pembrolizumab Induced Myocarditis and Complete Heart Block

Case: A Case of Pembrolizumab Induced Myocarditis and Complete Heart Block

Use of checkpoint inhibitor pembrolizumab has continued to grow since its approval in 2014. Rare instances of conduction side effects have been described including brady and tachyarrhythmias, heart block and even cardiac arrest. We present a case of Pembrolizumab induced myocarditis and persistent t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of community hospital internal medicine perspectives 2024-05, Vol.14 (3), p.77
Hauptverfasser: Adhikari, Janak, Sharma, Priyadarshani, Karnabi, Eddy, Merchan, Juan H, Arshad, Hasnain
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Use of checkpoint inhibitor pembrolizumab has continued to grow since its approval in 2014. Rare instances of conduction side effects have been described including brady and tachyarrhythmias, heart block and even cardiac arrest. We present a case of Pembrolizumab induced myocarditis and persistent third-degree heart block.
ISSN:2000-9666
2000-9666
DOI:10.55729/2000-9666.1329